Industry Roundtables


Sunday, July 16 3:00 - 4:30 p.m.

Running with Your Idea: How to Successfully Navigate Your Start-Up

Sponsored by Pfizer

Room: Grand/Liberty Ballroom
Moderator: Ramin Darvari, Pfizer

Are you an entrepreneur in the start-up phase? Have you always wished you were?  This discussion is focused on how entrepreneurs and large pharma fuel and benefit the other. The panel, with perspectives from academics, startups, investors, and large pharma, aims to provide a roadmap for flourishing, entrepreneurial ideas to products that will help patients.

Anthony Barry, Pfizer
Travis McCready, Mass Life Sciences Center
Sandra Glucksmann, previously Editas Medicine
Samir Mitragotri, Harvard


Monday, July 17 •  8:30 - 10:00 a.m.

New Advances in Lipid-Based Drug Delivery to Meet Advanced Industry and Patient Needs

Sponsored by Capsugel

Room: Independence Ballroom
Moderator: Hassan Benameur, Capsugel

Lipid-based drug delivery systems (LBDDS) have a long history in oral drug delivery, particularly for boosting absorption of poorly soluble drugs. More recently, there has been growing pharma pipeline demands for technologies that address the "next' barriers to oral bioavailability. This session highlights lipid-based drug delivery systems (LBDDS), with academic and industry experts to cover advances in these areas. The speakers will discuss how LBDDS can aid delivery of drugs showing low permeability, high first-pass metabolism and high melting point, and how industry is bringing the advantages of LBBDS to wider patient-groups including the elderly and children.

Brett Waybrant, Bend Research/Capsugel
Chris Porter, Monash Institute of Pharmaceutical Sciences
David Brayden, University College Dublin
Hywel Williams, Capsugel R&D
Neil Mathias, Bristol-Myers Squibb


Monday, July 17 1:15 - 2:45 p.m.

Drug Delivery 2017: The Path Ahead

Sponsored by Catalent

Room: Independence Ballroom
Moderator: Claus-Michael Lehr, Saarland University & Helmholtz Institute for Pharmaceutical Research

A diverse panel of experts from industry and academia will assess the current state of the small and large molecule drug delivery field, including formulation, dose forms, CMC, and devices. The panel will discuss strategies and approaches that are or are not working today, where further innovation is needed, and the evolving perspectives of different stakeholders (pharma, academia, regulators, patients, providers, and payers).

Jim Spavins, Spavins Consulting
Cornell Stamoran, Catalent Applied Drug Delivery Institute & Catalent Pharma Solutions
Randy Mrsny, University of Bath & Applied Molecular Transport
Debra Bingham, Valeo Partners


Monday, July 17 4:15 - 5:45 p.m.

New Methods to Mitigate Risks During Development

Sponsored by Cambridge Design Partnership 

Room: Independence Ballroom
Moderator: Uri Baruch, Cambridge Design Partnership

This session will focus on how we can mitigate risk early in the development cycle by using new technologies and learning from other business sectors. It will explore new methods that can provide insights into issues related to therapeutic effects, adherence, and user preferences, while also creating a shared view of the product profile across a diverse organization.

Panelists: TBD


Tuesday, July 18 8:30 - 10:00 a.m.

Patient Advocacy and Engagement

Room: Independence Ballroom
Moderator: Keith Horspool, Boehringer Ingelheim

This session will focus on patient advocacy and engagement from the perspectives of patients, patient advocacy organizations, and companies involved with pharmaceutical development. Our panelists will explore a broad range of experiences they’ve personally experienced or encountered, discussing how drug delivery and development scientists can better partner with patients to best meet their needs.

Mary Suzanne 'Suz' Schrandt, Arthritis Foundation
Nicole Rioles, T1D Exchange
Rubi Burlage, Merck
Matthew Burke, GSK


Tuesday, July 18 1:30 - 3:00 p.m.

Enabling Successful Delivery of Life Cycle Management Strategies through Effective Collaboration

Sponsored by Patheon

Room: Independence Ballroom
Moderator: Anil Kane, Patheon

Lifecycle management (LCM) is one of the major strategies used in the pharmaceutical industry owing to several factors such as the patent expiry of major blockbuster drugs in the coming 5-10 years, stiffer competition in the market due to the presence of generic players and a drought in the pharmaceutical R & D pipeline. Controlled Release dosage forms, Fixed Dose Combinations (FDC’s) and Pediatrics are some of the leading LCM strategies adopted by the industry. Emerging, Specialty Pharma companies as well as some Big Pharma may not have the required experience and expertise in-house or have the required infrastructure to successfully develop these drug products, prove clinical success and progress the drug (s) to a commercial launch. The pharma industry relies on the expertise and capacity of the Contract Development Manufacturing Organization (CDMO) who develops such strategies for multiple challenging products to develop these dosage forms. Trends in effective collaboration models for successful outcome with some case studies will be discussed by an expert panel of speakers.

Panelists: TBD


Wednesday, July 19 8:30 - 10:00 a.m.

Challenges and Prospects of Encapsulation and Controlled Delivery in Agriculture

Sponsored by Dow AgroSciences, Monsanto and Syngenta

Room: Independence Ballroom
Moderator: James F. Essinger, Gowan Co.

This session focuses on encapsulation in regards to technology, trends and opportunities in this market. The objective is to showcase different technologies and how encapsulation and controlled delivery can further enrich agricultural formulations. Topics to include: balancing herbicide activity and crop safety through microencapsulation, reinvigorating agrochemical products with microencapsulation technology and controlled release granules for rate reduction of neonicotinoids.

Alexander Schätz, Syngenta Crop Protection
William Abraham, Monsanto
Mei Li, Dow AgroSciences


© Copyright Controlled Release Society  | Contact Us - Report a Bad Link |
Admin Access